BioSyent (OTCMKTS:BIOYF) Stock Price Down 1.3% – What’s Next?

BioSyent Inc. (OTCMKTS:BIOYFGet Free Report)’s share price traded down 1.3% during trading on Friday . The company traded as low as $11.24 and last traded at $11.25. Approximately 3,188 shares were traded during trading, an increase of 25% from the average session volume of 2,541 shares. The stock had previously closed at $11.40.

BioSyent Stock Down 1.3%

The firm’s fifty day moving average price is $10.92 and its 200 day moving average price is $10.67.

About BioSyent

(Get Free Report)

BioSyent Inc is a specialty biopharmaceutical company focused on developing, manufacturing and commercializing pharmaceutical products and medical devices. The company leverages expertise in regulatory affairs, clinical development and manufacturing to deliver a range of branded and generic therapies across multiple therapeutic areas, with particular emphasis on endocrine disorders, supportive care oncology and dermatology.

BioSyent operates a manufacturing facility in Canada that supports both its proprietary portfolio and contract development and manufacturing services (CDMO) for small-molecule products.

Featured Articles

Receive News & Ratings for BioSyent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioSyent and related companies with MarketBeat.com's FREE daily email newsletter.